-
2
-
-
84908122111
-
Systemic treatment of soft-tissue sarcoma-gold standard and novel therapies
-
Linch M, Miah AB, Thway K, Judson IR and Benson C. Systemic treatment of soft-tissue sarcoma-gold standard and novel therapies. Nat Rev Clin Oncol 2014; 11: 187-202.
-
(2014)
Nat Rev Clin Oncol
, vol.11
, pp. 187-202
-
-
Linch, M.1
Miah, A.B.2
Thway, K.3
Judson, I.R.4
Benson, C.5
-
3
-
-
80053062871
-
Preliminary efficacy of the antiinsulin-like growth factor type 1 receptor antibody figitumumab in patients with refractory Ewing sarcoma
-
Juergens H, Daw NC, Geoerger B, Ferrari S, Villarroel M, Aerts I, Whelan J, Dirksen U, Hixon ML, Yin D, Wang T, Green S, Paccagnella L and Gualberto A. Preliminary efficacy of the antiinsulin-like growth factor type 1 receptor antibody figitumumab in patients with refractory Ewing sarcoma. J Clin Oncol 2011; 29: 4534- 4540.
-
(2011)
J Clin Oncol
, vol.29
-
-
Juergens, H.1
Daw, N.C.2
Geoerger, B.3
Ferrari, S.4
Villarroel, M.5
Aerts, I.6
Whelan, J.7
Dirksen, U.8
Hixon, M.L.9
Yin, D.10
Wang, T.11
Green, S.12
Paccagnella, L.13
Gualberto, A.14
-
4
-
-
70350569295
-
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors
-
Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C, Vermaelen K, Panaretakis T, Mignot G, Ullrich E, Perfettini JL, Schlemmer F, Tasdemir E, Uhl M, Genin P, Civas A, Ryffel B, Kanellopoulos J, Tschopp J, Andre F, Lidereau R, McLaughlin NM, Haynes NM, Smyth MJ, Kroemer G and Zitvogel L. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 2009; 15: 1170-1178.
-
(2009)
Nat Med
, vol.15
, pp. 1170-1178
-
-
Ghiringhelli, F.1
Apetoh, L.2
Tesniere, A.3
Aymeric, L.4
Ma, Y.5
Ortiz, C.6
Vermaelen, K.7
Panaretakis, T.8
Mignot, G.9
Ullrich, E.10
Perfettini, J.L.11
Schlemmer, F.12
Tasdemir, E.13
Uhl, M.14
Genin, P.15
Civas, A.16
Ryffel, B.17
Kanellopoulos, J.18
Tschopp, J.19
Re, F.20
Lidereau, R.21
McLaughlin, N.M.22
Haynes, N.M.23
Smyth, M.J.24
Kroemer, G.25
Zitvogel, L.26
more..
-
5
-
-
60349123127
-
Purinergic receptor-mediated effects of adenosine 5’-triphosphate in urological malignant diseases
-
Shabbir M and Burnstock G. Purinergic receptor-mediated effects of adenosine 5’-triphosphate in urological malignant diseases. Int J Urol 2009; 16: 143-150.
-
(2009)
Int J Urol
, vol.16
, pp. 143-150
-
-
Shabbir, M.1
Burnstock, G.2
-
6
-
-
41949083203
-
Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade
-
Yegutkin GG. Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade. Biochim Biophys Acta 2008; 1783: 673-694.
-
(2008)
Biochim Biophys Acta
, vol.1783
, pp. 673-694
-
-
Yegutkin, G.G.1
-
7
-
-
0029664401
-
CD39 is an ecto-(Ca2+, Mg2+)-apyrase
-
Wang TF and Guidotti G. CD39 is an ecto-(Ca2+, Mg2+)-apyrase. J Biol Chem 1996; 271: 9898-9901.
-
(1996)
J Biol Chem
, vol.271
, pp. 9898-9901
-
-
Wang, T.F.1
Guidotti, G.2
-
8
-
-
77957564570
-
Extracellular adenosine triphosphate and adenosine in cancer
-
Stagg J and Smyth MJ. Extracellular adenosine triphosphate and adenosine in cancer. Oncogene 2010; 29: 5346-5358.
-
(2010)
Oncogene
, vol.29
, pp. 5346-5358
-
-
Stagg, J.1
Smyth, M.J.2
-
9
-
-
33748357735
-
A2A adenosine receptor protects tumors from antitumor T cells
-
Ohta A, Gorelik E, Prasad SJ, Ronchese F, Lukashev D, Wong MK, Huang X, Caldwell S, Liu K, Smith P, Chen JF, Jackson EK, Apasov S, Abrams S and Sitkovsky M. A2A adenosine receptor protects tumors from antitumor T cells. Proc Natl Acad Sci U S A 2006; 103: 13132-13137.
-
(2006)
Proc Natl Acad Sci U S A
, vol.103
, pp. 13132-13137
-
-
Ohta, A.1
Gorelik, E.2
Prasad, S.J.3
Ronchese, F.4
Lukashev, D.5
Wong, M.K.6
Huang, X.7
Caldwell, S.8
Liu, K.9
Smith, P.10
Chen, J.F.11
Jackson, E.K.12
Apasov, S.13
Abrams, S.14
Sitkovsky, M.15
-
10
-
-
85047689068
-
CD39 expression on T lymphocytes correlates with severity of disease in patients with chronic lymphocytic leukemia
-
Pulte D, Furman RR, Broekman MJ, Drosopoulos JH, Ballard HS, Olson KE, Kizer JR and Marcus AJ. CD39 expression on T lymphocytes correlates with severity of disease in patients with chronic lymphocytic leukemia. Clin Lymphoma Myeloma Leuk 2011; 11: 367-372.
-
(2011)
Clin Lymphoma Myeloma Leuk
, vol.11
, pp. 367-372
-
-
Pulte, D.1
Furman, R.R.2
Broekman, M.J.3
Drosopoulos, J.H.4
Ballard, H.S.5
Olson, K.E.6
Kizer, J.R.7
Marcus, A.J.8
-
11
-
-
84876125245
-
ENTPD1/CD39 is a promising therapeutic target in oncology
-
Bastid J, Cottalorda-Regairaz A, Alberici G, Bonnefoy N, Eliaou JF and Bensussan A. ENTPD1/CD39 is a promising therapeutic target in oncology. Oncogene 2013; 32: 1743-1751.
-
(2013)
Oncogene
, vol.32
, pp. 1743-1751
-
-
Bastid, J.1
Cottalorda-Regairaz, A.2
Alberici, G.3
Bonnefoy, N.4
Eliaou, J.F.5
Bensussan, A.6
-
12
-
-
84937874129
-
Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity
-
Bastid J, Regairaz A, Bonnefoy N, Dejou C, Giustiniani J, Laheurte C, Cochaud S, Laprevotte E, Funck-Brentano E, Hemon P, Gros L, Bec N, Larroque C, Alberici G, Bensussan A and Eliaou JF. Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity. Cancer Immunol Res 2015; 3: 254-265.
-
(2015)
Cancer Immunol Res
, vol.3
, pp. 254-265
-
-
Bastid, J.1
Regairaz, A.2
Bonnefoy, N.3
Dejou, C.4
Giustiniani, J.5
Laheurte, C.6
Cochaud, S.7
Laprevotte, E.8
Funck-Brentano, E.9
Hemon, P.10
Gros, L.11
Bec, N.12
Larroque, C.13
Alberici, G.14
Bensussan, A.15
Eliaou, J.F.16
-
13
-
-
34250351459
-
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
-
Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, Chen JF, Enjyoji K, Linden J, Oukka M, Kuchroo VK, Strom TB and Robson SC. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007; 204: 1257-1265.
-
(2007)
J Exp Med
, vol.204
, pp. 1257-1265
-
-
Deaglio, S.1
Dwyer, K.M.2
Gao, W.3
Friedman, D.4
Usheva, A.5
Erat, A.6
Chen, J.F.7
Enjyoji, K.8
Linden, J.9
Oukka, M.10
Kuchroo, V.K.11
Strom, T.B.12
Robson, S.C.13
-
14
-
-
79952414321
-
Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate
-
Feng L, Sun X, Csizmadia E, Han L, Bian S, Murakami T, Wang X, Robson SC and Wu Y. Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate. Neoplasia 2011; 13: 206-216.
-
(2011)
Neoplasia
, vol.13
, pp. 206-216
-
-
Feng, L.1
Sun, X.2
Csizmadia, E.3
Han, L.4
Bian, S.5
Murakami, T.6
Wang, X.7
Robson, S.C.8
Wu, Y.9
-
15
-
-
84964315622
-
Hostile, hypoxia-A2-adenosinergic tumor biology as the next barrier to overcome for tumor immunologists
-
Sitkovsky MV, Hatfield S, Abbott R, Belikoff B, Lukashev D and Ohta A. Hostile, hypoxia-A2-adenosinergic tumor biology as the next barrier to overcome for tumor immunologists. Cancer Immunol Res 2014; 2: 598-605.
-
(2014)
Cancer Immunol Res
, vol.2
, pp. 598-605
-
-
Sitkovsky, M.V.1
Hatfield, S.2
Abbott, R.3
Belikoff, B.4
Lukashev, D.5
Ohta, A.6
-
17
-
-
17444408134
-
Polyoxometalates: Introduction to a class of inorganic compounds and their biomedical applications
-
Hasenknopf B. Polyoxometalates: introduction to a class of inorganic compounds and their biomedical applications. Front Biosci 2005; 10: 275-287.
-
(2005)
Front Biosci
, vol.10
, pp. 275-287
-
-
Hasenknopf, B.1
-
18
-
-
84892958157
-
Anti-CD39 and anti-CD73 antibodies A1 and 7G2 improve targeted therapy in ovarian cancer by blocking adenosine-dependent immune evasion
-
Hausler SF, Del Barrio IM, Diessner J, Stein RG, Strohschein J, Honig A, Dietl J and Wischhusen J. Anti-CD39 and anti-CD73 antibodies A1 and 7G2 improve targeted therapy in ovarian cancer by blocking adenosine-dependent immune evasion. Am J Transl Res 2014; 6: 129-139.
-
(2014)
Am J Transl Res
, vol.6
, pp. 129-139
-
-
Hausler, S.F.1
Del Barrio, I.M.2
Diessner, J.3
Stein, R.G.4
Strohschein, J.5
Honig, A.6
Dietl, J.7
Wischhusen, J.8
-
19
-
-
77956627540
-
Comparative analysis of techniques to purify plasma membrane proteins
-
Weekes MP, Antrobus R, Lill JR, Duncan LM, Hor S and Lehner PJ. Comparative analysis of techniques to purify plasma membrane proteins. J Biomol Tech 2010; 21: 108-115.
-
(2010)
J Biomol Tech
, vol.21
, pp. 108-115
-
-
Weekes, M.P.1
Antrobus, R.2
Lill, J.R.3
Duncan, L.M.4
Hor, S.5
Lehner, P.J.6
-
20
-
-
79551500036
-
Less label, more free: Approaches in label-free quantitative mass spectrometry
-
Neilson KA, Ali NA, Muralidharan S, Mirzaei M, Mariani M, Assadourian G, Lee A, van Sluyter SC and Haynes PA. Less label, more free: approaches in label-free quantitative mass spectrometry. Proteomics 2011; 11: 535-553.
-
(2011)
Proteomics
, vol.11
, pp. 535-553
-
-
Neilson, K.A.1
Ali, N.A.2
Muralidharan, S.3
Mirzaei, M.4
Mariani, M.5
Assadourian, G.6
Lee, A.7
Van Sluyter, S.C.8
Haynes, P.A.9
-
21
-
-
84897112155
-
Monoclonal antibody binding-site diversity assessment with a cell-based clustering assay
-
Liao-Chan S, Zachwieja J, Gomez S, Duey D, Lippincott J and Theunissen JW. Monoclonal antibody binding-site diversity assessment with a cell-based clustering assay. J Immunol Methods 2014; 405: 1-14.
-
(2014)
J Immunol Methods
, vol.405
, pp. 1-14
-
-
Liao-Chan, S.1
Zachwieja, J.2
Gomez, S.3
Duey, D.4
Lippincott, J.5
Theunissen, J.W.6
-
22
-
-
84876459471
-
A novel flow cytometry-based platelet aggregation assay
-
De Cuyper IM, Meinders M, van de Vijver E, de Korte D, Porcelijn L, de Haas M, Eble JA, Seeger K, Rutella S, Pagliara D, Kuijpers TW, Verhoeven AJ, van den Berg TK and Gutierrez L. A novel flow cytometry-based platelet aggregation assay. Blood 2013; 121: e70-80.
-
(2013)
Blood
, vol.121
, pp. e70-e80
-
-
De Cuyper, I.M.1
Meinders, M.2
Van De Vijver, E.3
De Korte, D.4
Porcelijn, L.5
De Haas, M.6
Eble, J.A.7
Seeger, K.8
Rutella, S.9
Pagliara, D.10
Kuijpers, T.W.11
Verhoeven, A.J.12
Van Den Berg, T.K.13
Gutierrez, L.14
-
23
-
-
53549101310
-
Quantitative flow cytometric analysis of membrane antigen expression
-
Chapter 6: Unit 6 12
-
D’Hautcourt JL. Quantitative flow cytometric analysis of membrane antigen expression. Curr Protoc Cytom 2002; Chapter 6: Unit 6 12
-
(2002)
Curr Protoc Cytom
-
-
D’Hautcourt, J.L.1
-
24
-
-
20744439988
-
Altered membrane NTPase activity in Lesch-Nyhan disease fibroblasts: Comparison with HPRT knockout mice and HPRT-deficient cell lines
-
Pinto CS, Jinnah HA, Shirley TL, Nyhan WL and Seifert R. Altered membrane NTPase activity in Lesch-Nyhan disease fibroblasts: comparison with HPRT knockout mice and HPRT-deficient cell lines. J Neurochem 2005; 93: 1579-1586.
-
(2005)
J Neurochem
, vol.93
, pp. 1579-1586
-
-
Pinto, C.S.1
Jinnah, H.A.2
Shirley, T.L.3
Nyhan, W.L.4
Seifert, R.5
-
25
-
-
65549135781
-
Discovery of fully human anti-MET monoclonal antibodies with antitumor activity against colon cancer tumor models in vivo
-
van der Horst EH, Chinn L, Wang M, Velilla T, Tran H, Madrona Y, Lam A, Ji M, Hoey TC and Sato AK. Discovery of fully human anti-MET monoclonal antibodies with antitumor activity against colon cancer tumor models in vivo. Neoplasia 2009; 11: 355-364.
-
(2009)
Neoplasia
, vol.11
, pp. 355-364
-
-
Van Der Horst, E.H.1
Chinn, L.2
Wang, M.3
Velilla, T.4
Tran, H.5
Madrona, Y.6
Lam, A.7
Ji, M.8
Hoey, T.C.9
Sato, A.K.10
-
26
-
-
84896748416
-
WHO classification of soft tissue tumours: An update based on the 2013 (4th) edition
-
Jo VY and Fletcher CD. WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. Pathology 2014; 46: 95-104.
-
(2014)
Pathology
, vol.46
, pp. 95-104
-
-
Jo, V.Y.1
Fletcher, C.D.2
-
27
-
-
33750523406
-
Polyoxometalates—a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors
-
Muller CE, Iqbal J, Baqi Y, Zimmermann H, Rollich A and Stephan H. Polyoxometalates—a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors. Bioorg Med Chem Lett 2006; 16: 5943-5947.
-
(2006)
Bioorg Med Chem Lett
, vol.16
, pp. 5943-5947
-
-
Muller, C.E.1
Iqbal, J.2
Baqi, Y.3
Zimmermann, H.4
Rollich, A.5
Stephan, H.6
-
28
-
-
84906895091
-
Patientderived xenograft models: An emerging platform for translational cancer research
-
Hidalgo M, Amant F, Biankin AV, Budinska E, Byrne AT, Caldas C, Clarke RB, de Jong S, Jonkers J, Maelandsmo GM, Roman-Roman S, Seoane J, Trusolino L and Villanueva A. Patientderived xenograft models: an emerging platform for translational cancer research. Cancer Discov 2014; 4: 998-1013.
-
(2014)
Cancer Discov
, vol.4
, pp. 998-1013
-
-
Hidalgo, M.1
Amant, F.2
Biankin, A.V.3
Budinska, E.4
Byrne, A.T.5
Caldas, C.6
Clarke, R.B.7
De Jong, S.8
Jonkers, J.9
Maelandsmo, G.M.10
Roman-Roman, S.11
Seoane, J.12
Trusolino, L.13
Villanueva, A.14
-
29
-
-
18344410760
-
NOD/SCID/gamma(C) (null) mouse: An excellent recipient mouse model for engraftment of human cells
-
Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, Ueyama Y, Koyanagi Y, Sugamura K, Tsuji K, Heike T and Nakahata T. NOD/SCID/gamma(c) (null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 2002; 100: 3175-3182.
-
(2002)
Blood
, vol.100
, pp. 3175-3182
-
-
Ito, M.1
Hiramatsu, H.2
Kobayashi, K.3
Suzue, K.4
Kawahata, M.5
Hioki, K.6
Ueyama, Y.7
Koyanagi, Y.8
Sugamura, K.9
Tsuji, K.10
Heike, T.11
Nakahata, T.12
|